oral contraceptives

Hormonal contraception and breast cancer: Is there a link?Results of a prospective cohort study by Danish investigators suggest that current or recent use of hormonal contraceptives may be associated with an increased risk of breast cancer. Plus, Editorial Board Member, Ilana Cass, MD, weighs in on the impact of the study's findings.
Hormonal therapies effective for acneHormonal therapies are an effective strategy to improve acne in women but some of these treatments, including birth control pills, are not commonly prescribed.
Does OC use lead to longer progression-free survival in ovarian cancer?A look at whether or not oral contraceptives help with ovarian cancer survival. Plus: Do false-positive mammogram results serve as a sign of future breast cancer risk?
Oral contraceptives effective for long-term acne treatmentHormonal therapy is effective in treating acne, but patients will likely have to remain on hormonal therapy long-term to maintain the benefits.
Idarucizumab for dabigatran reversalResults from the REVERSE-AD prospective cohort study.
Should pharmacists be allowed to prescribe oral contraceptives?At least one Oregon state legislator believes allowing pharmacists to prescribe oral contraceptives would increase access to birth control and reduce unwanted pregnancies.
Babies of young teens at high risk of complicationsNASPAG 29th conference featured research on the increased risk of complications in teen pregnancy, the desire on over-the-counter contraception, and a tool to help identify patients with menorrhagia.
Ob/gyn Stat Bite: Use of ContraceptionA valuable infographic showing types of contraception used by American women of various ages, education levels, and ethnicities.
OCPs match antibiotics in acne treatmentThough it’s known that oral contraceptive pills (OCPs) and systemic antibiotics are both effective in managing acne, there’s been precious little research comparing the two therapies head-to-head — until now.
Does recent OC use impact breast cancer risk?A National Cancer Institute-funded case control study suggests that some current formulations of oral contraception (OCs) may increase risk of breast cancer.